… are that severe COVID-19 differs from conventional pneumonia by a specific blood cytokine
profile. Several … While some blood biomarkers are significantly elevated in severe COVID-…

… for worse outcome of COVID-19. Among various … high mortality from COVID-19. An attempt
to understand the pathophysiology of various hematological abnormalities including cytokine …

… Our findings could also explain why the administration of glucocorticoids, in particular
dexamethasone, which decreases blood levels of many cytokines, was successful in both patients …

… Demographic and clinical data of patients diagnosed with COVID19 pneumonia whose
peripheral blood cytokines were tested were collected. Serum samples from age-matched …

… inflammatory cytokines have role in COVID-19 severity and … with the keywords “COVID-19″
and “cytokines”. The data were … cytokines are risk factors for severity and mortality of COVID-…

… cytokines. This research studies the correlation of the released cytokines with mortality or
lung injury in COVID-19 … 40 patients diagnosed with COVID-19 in the COVID-19 Department, …

… Furthermore, in a daily transcriptomic profiling of whole blood from COVID-19 patients, the
… These clinical data raise the critical question of which member(s) of the COVID-19 cytokine …

… More than 70% of the deaths related to COVID‐19 are associated with deregulation of
the mechanisms that control blood clotting, as a part of the innate immune response to limit …

… Cumulative data indicated that COVID-19 significantly influenced the distribution of blood
CD4 T cell lineages. Indeed, the proportion of T helper type 1 (Th1) (CXCR3 + Tbet + ), Th17 …

… blood endothelial cells that express ACE2, we hypothesize that IL-6 inhibitors including TCZ
could mitigate cytokine storms in COVID-19 … -6 inhibitors could suppress cytokine storms in …